Related Experiment Videos
Intraocular lenses and experimental bacterial endophthalmitis
American Journal of Ophthalmology
|September 1, 1982
Summary
Intraocular lenses (IOLs) did not affect bacterial endophthalmitis resistance to gentamicin therapy in a rabbit model. Both pseudophakic and aphakic eyes showed similar responses to antibiotic treatment for Staphylococcus aureus infections.
Area of Science:
- Ophthalmology
- Microbiology
- Medical Technology
Background:
- Bacterial endophthalmitis is a severe intraocular infection.
- Intraocular lenses (IOLs) are commonly implanted during cataract surgery.
- The impact of IOLs on the efficacy of endophthalmitis treatment is not fully understood.
Purpose of the Study:
- To investigate whether the presence of an intraocular lens (IOL) influences the resistance of bacterial endophthalmitis to antibiotic therapy.
- To compare treatment outcomes in eyes with and without an IOL following experimental Staphylococcus aureus inoculation.
Main Methods:
- An animal model using rabbits was developed for bacterial endophthalmitis.
- Rabbits underwent lens extraction and IOL implantation in one eye (pseudophakic), while the other remained aphakic.
- Both eyes were inoculated with Staphylococcus aureus and treated with intravitreal and subconjunctival gentamicin.
- Clinical response and vitreous cultures were monitored.
Main Results:
- Vitreous cultures remained sterile in all treated eyes for one week post-antibiotic therapy.
- Two untreated animals showed persistent infection, confirming model viability.
- No significant difference was observed in clinical response or time to sterile cultures between aphakic and pseudophakic eyes.
Conclusions:
- The presence of a posterior chamber intraocular lens does not appear to confer increased resistance to bacterial endophthalmitis.
- Standard gentamicin therapy was effective in clearing Staphylococcus aureus from both pseudophakic and aphakic rabbit eyes.
- These findings suggest IOL implantation does not complicate endophthalmitis treatment efficacy.